A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302

Oncology ◽  
2019 ◽  
Vol 97 (6) ◽  
pp. 327-333
Author(s):  
Satoshi Ikeda ◽  
Hiroshige Yoshioka ◽  
Toshihiko Kaneda ◽  
Toshihide Yokoyama ◽  
Takashi Niwa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Research Group ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Oncology Research

Salvage treatment of relapsed/refractory small cell lung cancer with pazopanib: A Hellenic Oncology Research Group’s (HORG) phase II study.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 8561-8561
Author(s):  
Athanasios Kotsakis ◽  
Vasilis Karavasilis ◽  
Sofia Agelaki ◽  
Nikolaos K. Kentepozidis ◽  
Stavros Peroukidis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Salvage Treatment ◽  
Small Cell ◽  
Small Cell Lung ◽  
Oncology Research
Sign in / Sign up

Export Citation Format

Share Document